D.A. Davidson & Co. Intercept Pharmaceuticals, Inc. Transaction History

D.A. Davidson & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$46.7 - $92.04 $206,414 - $406,816	-4,420 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$48.35 - $118.68 $103,759 - $254,687	-2,146 Reduced 32.68%	4,420 $278,000
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $181,314 - $392,280	3,161 Added 92.83%	6,566 $814,000
Q3 2019 Nov 05, 2019	BUY	$58.69 - $80.46 $199,839 - $273,966	3,405 New	3,405 $226,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.